(Alliance News) - The board of Svas Biosana Spa has approved the financial statements for 2023,in which it reported revenues from ordinary operations of EUR118.3 million, an increase of 22% from December 31, 2022. Net income was positive at EUR5.1 million, up more than 43% from the previous year.

The board approved the distribution of a dividend of EUR0.30 per share

Ebitda amounted to EUR14.2 million up 20%, with an Ebitda margin of 12.0% on revenues.

The Net Financial Position is cash negative EUR23.8 million, an improvement over the cash negative NFP of EUR25.2 million as of June 30, 2023.

"We are very satisfied with the results for fiscal year 2023, the best ever, which further consolidate the Group's market position, confirming a growth that is now structural," commented CEO Umberto Perillo. "The prudent management, the investments to improve productivity and the focus on the quality of products and services, have allowed us to achieve the excellent results we are proud of, despite the increase in input costs. The goal is to continue investing in innovation in order to provide our customers with increasingly effective solutions."

Svas Biosana closed Monday's session in the green by 2.5 percent at EUR8.35 per share

By Maurizio Carta, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2024 Alliance News IS Italian Service Ltd. All rights reserved.